← Open Payments lookup

RAMON RAVELO: Open Payments

NPI 1437172426 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,033 in 126 payments from 13 companies in 2025. Trend: 2023 $2,174 · 2024 $2,661 · 2025 $3,033

Food & beverage: $2,854Education: $179
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.21$538
Vanda Pharmaceuticals Inc.16$531
ABBVIE INC.23$472
Axsome Therapeutics, Inc.10$424
Alkermes, Inc.19$315
Neurocrine BioSciences, Inc.9$218
Otsuka America Pharmaceutical, Inc.13$201
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$86
Validus Pharmaceuticals LLC3$69
Lundbeck LLC3$59

Products named: VRAYLAR, Auvelity, AUSTEDO XR, ARISTADA, HETLIOZ, FANAPT, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across NY — which companies pay providers there.